Literature DB >> 18633337

C3 deposition glomerulopathy due to a functional factor H defect.

Sandra Habbig1, Michael J Mihatsch2, Stefan Heinen3, Bodo Beck1, Mathias Emmel4, Christine Skerka3, Michael Kirschfink5, Bernd Hoppe1, Peter F Zipfel6, Christoph Licht7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18633337     DOI： 10.1038/ki.2008.354

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  38 in total

1.  Eculizumab for dense deposit disease and C3 glomerulonephritis.

Authors:  Andrew S Bomback; Richard J Smith; Gaetano R Barile; Yuzhou Zhang; Eliot C Heher; Leal Herlitz; M Barry Stokes; Glen S Markowitz; Vivette D D'Agati; Pietro A Canetta; Jai Radhakrishnan; Gerald B Appel
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 8.237

2.  Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.

Authors:  Valérie Leroy; Véronique Fremeaux-Bacchi; Michel Peuchmaur; Véronique Baudouin; Georges Deschênes; Marie-Alice Macher; Chantal Loirat
Journal:  Pediatr Nephrol       Date:  2010-12-25       Impact factor: 3.714

3.  Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.

Authors:  Jennifer Laskowski; Brandon Renner; Moglie Le Quintrec; Sarah Panzer; Jonathan P Hannan; Danica Ljubanovic; Marieta M Ruseva; Dorin-Bogdan Borza; Alexandra H Antonioli; Matthew C Pickering; V Michael Holers; Joshua M Thurman
Journal:  Kidney Int       Date:  2016-05-07       Impact factor: 10.612

Review 4.  C3 Glomerulopathy.

Authors:  Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-04-07       Impact factor: 3.714

5.  Rituximab fails where eculizumab restores renal function in C3nef-related DDD.

Authors:  Caroline Rousset-Rouvière; Mathilde Cailliez; Florentine Garaix; Daniele Bruno; Daniel Laurent; Michel Tsimaratos
Journal:  Pediatr Nephrol       Date:  2014-01-10       Impact factor: 3.714

Review 6.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

7.  A rare case: childhood-onset C3 glomerulonephritis due to homozygous factor H deficiency.

Authors:  Krisztina Rusai; Vera Zaller; Agnes Szilagyi; Renate Kain; Zoltan Prohaszka; H Terence Cook; Christoph Aufricht; Klaus Arbeiter
Journal:  CEN Case Rep       Date:  2013-03-16

8.  Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.

Authors:  Fadi Fakhouri; Elena Goicoechea de Jorge; Frédérique Brune; Philippe Azam; H Terence Cook; Matthew C Pickering
Journal:  Kidney Int       Date:  2010-05-05       Impact factor: 10.612

Review 9.  Update on membranoproliferative GN.

Authors:  Naveed Masani; Kenar D Jhaveri; Steven Fishbane
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 8.237

Review 10.  Treatment options for C3 glomerulopathy.

Authors:  Carla M Nester; Richard J Smith
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-03       Impact factor: 2.894
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.